Health X Platform Promoter Group Increases Stake to 74.84% Through Market Purchases
Health X Platform Limited disclosed promoter group acquisitions totaling 1,90,355 shares through market purchases between November 2025 and March 2026. The promoter group's collective shareholding increased from 74.24% to 74.84%, with Banwari Lal Mittal acquiring 1,70,355 shares to reach 33.91% individual holding and Luv Kush Projects Limited adding 20,000 shares to achieve 11.96% stake.

*this image is generated using AI for illustrative purposes only.
Health X Platform Limited (formerly Sastasundar Ventures Limited) has disclosed substantial share acquisitions by its promoter group under SEBI Takeover Regulations. The comprehensive acquisition involved multiple transactions between November 2025 and March 2026, demonstrating sustained confidence in the company's prospects.
Promoter Group Acquisition Details
The promoter group, led by Banwari Lal Mittal, acquired a total of 1,90,355 equity shares through market purchases. The acquisition period spanned from November 17, 2025, to March 24, 2026, with transactions conducted on the open market.
| Parameter: | Details |
|---|---|
| Total Shares Acquired: | 1,90,355 equity shares |
| Acquisition Period: | November 17, 2025 to March 24, 2026 |
| Transaction Mode: | Market Purchase |
| Percentage Increase: | 0.5984% |
| Stock Exchanges: | BSE (533259) and NSE (SASTASUNDR) |
Updated Promoter Group Shareholding Pattern
The acquisitions resulted in a significant increase in the promoter group's collective shareholding. The group's total holding now represents nearly three-quarters of the company's equity capital.
| Shareholding Status: | Before Acquisition | After Acquisition | Change |
|---|---|---|---|
| Total Promoter Shares: | 2,36,15,272 | 2,38,05,627 | +1,90,355 |
| Percentage Holding: | 74.24% | 74.84% | +0.60% |
| Equity Share Capital: | 3,18,10,500 shares | 3,18,10,500 shares | No change |
Individual Promoter Holdings
Banwari Lal Mittal emerged as the primary acquirer within the promoter group, significantly increasing his individual stake. Luv Kush Projects Limited also participated in the acquisition drive.
| Promoter Name: | Shares Acquired | New Holding | New Percentage |
|---|---|---|---|
| Banwari Lal Mittal: | 1,70,355 | 1,07,86,355 | 33.91% |
| Luv Kush Projects Limited: | 20,000 | 38,05,234 | 11.96% |
| Other Promoters: | No change | - | - |
Regulatory Compliance and Disclosure
Health X Platform Limited fulfilled its regulatory obligations by submitting the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The disclosure was communicated to both BSE and NSE on March 27, 2026.
Key compliance highlights include:
- Comprehensive promoter group details provided
- Timely disclosure within prescribed timeframes
- Proper documentation with acquirer signatures
- Communication to designated stock exchanges
- Complete shareholding pattern transparency
The company operates under ISIN INE019J01013 and maintains listings on both major Indian stock exchanges. The continued acquisitions reflect the promoter group's sustained investment confidence and strategic commitment to the company's growth trajectory.
Historical Stock Returns for Sastasundar Ventures
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +5.08% | -2.56% | -4.68% | -11.49% | +6.73% | +136.95% |
What strategic initiatives or expansion plans might Health X Platform be pursuing that prompted such sustained promoter confidence over this 4-month acquisition period?
How might the increased promoter concentration at 74.84% affect minority shareholder interests and the company's ability to raise external capital for future growth?
Could this significant promoter stake increase signal preparation for a potential delisting or privatization of Health X Platform?


































